Obinutuzumab in Refractory Membranous Nephropathy: A Case Series

Rationale & Objective: Membranous nephropathy (MN), recognized as an autoimmune kidney disease, responds well to anti-CD20 monoclonal antibodies. Obinutuzumab, a type Ⅱ humanized anti-CD20 and immunoglobulin G1 Fc-optimized monoclonal antibody, when compared with rituximab, has demonstrated...

全面介紹

書目詳細資料

發表在:	Kidney Medicine
Main Authors:	Yuxin Lin, Quan Han, Liangliang Chen, Yaomin Wang, Pingping Ren, Guangjun Liu, Lan Lan, Xin Lei, Jianghua Chen, Fei Han
格式:	Article
語言:	英语
出版:	Elsevier 2024-08-01
主題:	Obinutuzumab membranous nephropathy rituximab remission
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2590059524000645